Genomics

Dataset Information

Metronomic administration of topotecan alone and in combination with docetaxel inhibits epithelial-mesenchymal transition in aggressive variant prostate cancers


ABSTRACT: Metronomic administration of topotecan alone and in combination with docetaxel inhibits epithelial-mesenchymal transition in aggressive variant prostate cancers

PROVIDER: PRJNA975943 | ENA |

REPOSITORIES: ENA